AE

Allen Ebens

Prescient Therapeutics Limited | Non-Executive Director
Dr Ebens was formerly head of Research at Vera Therapeutics, a San Francisco based, clinical stage biotechnology company. He was recruit to Juno Therapeutics. He held senior executive positions at global pharma and biotechnology leaders Genentech and Exelixis, where he worked from concept to clinic across multiple therapeutic platforms including targeted smallmolecule therapies, antibodies, antibody-drug conjugates, and T cell recruiting antibodies. He is a member of the Risk Committee.

Company and Role

Company
Title
Tenure
Since
PTX
Prescient Therapeutics Limited
  • Non-Executive Director
6yrs, 4mthJun 2020

Holding

Company
Last Notice
Direct Shares
Indirect Shares
Options
Convertibles
PTX
Prescient Therapeutics Limited
20/08/26N/AN/A2,628,787N/A

Transactions

Company
Date
Type
Amount
Price
Value
Notes
PTX
Prescient Therapeutics Limited
18/11/25
Issued
2,628,787$0.048$126,181Issue of options
PTX
Prescient Therapeutics Limited
10/12/20
Issued
1,000,000$0.064$64,000Issue of options